These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 20631139)

  • 1. Leukocyte immunoglobulin-like receptors maintain unique antigen-presenting properties of circulating myeloid dendritic cells in HIV-1-infected elite controllers.
    Huang J; Burke PS; Cung TD; Pereyra F; Toth I; Walker BD; Borges L; Lichterfeld M; Yu XG
    J Virol; 2010 Sep; 84(18):9463-71. PubMed ID: 20631139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble HLA-G inhibits myeloid dendritic cell function in HIV-1 infection by interacting with leukocyte immunoglobulin-like receptor B2.
    Huang J; Burke P; Yang Y; Seiss K; Beamon J; Cung T; Toth I; Pereyra F; Lichterfeld M; Yu XG
    J Virol; 2010 Oct; 84(20):10784-91. PubMed ID: 20702625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic inhibition of myeloid dendritic cells by circulating HLA class I molecules in HIV-1 infection.
    Huang J; Al-Mozaini M; Rogich J; Carrington MF; Seiss K; Pereyra F; Lichterfeld M; Yu XG
    Retrovirology; 2012 Jan; 9():11. PubMed ID: 22289474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21.
    Chen H; Li C; Huang J; Cung T; Seiss K; Beamon J; Carrington MF; Porter LC; Burke PS; Yang Y; Ryan BJ; Liu R; Weiss RH; Pereyra F; Cress WD; Brass AL; Rosenberg ES; Walker BD; Yu XG; Lichterfeld M
    J Clin Invest; 2011 Apr; 121(4):1549-60. PubMed ID: 21403397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass Cytometry Analysis Reveals Complex Cell-State Modifications of Blood Myeloid Cells During HIV Infection.
    Coindre S; Tchitchek N; Alaoui L; Vaslin B; Bourgeois C; Goujard C; Lecuroux C; Bruhns P; Le Grand R; Beignon AS; Lambotte O; Favier B
    Front Immunol; 2019; 10():2677. PubMed ID: 31824485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cell dysfunction during primary HIV-1 infection.
    Huang J; Yang Y; Al-Mozaini M; Burke PS; Beamon J; Carrington MF; Seiss K; Rychert J; Rosenberg ES; Lichterfeld M; Yu XG
    J Infect Dis; 2011 Nov; 204(10):1557-62. PubMed ID: 21969335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukocyte Ig-Like receptor B1 restrains dendritic cell function through increased expression of the NF-κB regulator ABIN1/TNIP1.
    Khanolkar RC; Kalogeropoulos M; Lawrie A; Roghanian A; Vickers MA; Young NT
    J Leukoc Biol; 2016 Oct; 100(4):737-746. PubMed ID: 27129285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emerging role of leukocyte immunoglobulin-like receptors (LILRs) in HIV-1 infection.
    Lichterfeld M; Yu XG
    J Leukoc Biol; 2012 Jan; 91(1):27-33. PubMed ID: 22028331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inhibitory receptor LILRB1 modulates the differentiation and regulatory potential of human dendritic cells.
    Young NT; Waller EC; Patel R; Roghanian A; Austyn JM; Trowsdale J
    Blood; 2008 Mar; 111(6):3090-6. PubMed ID: 18094328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher SLPI expression, lower immune activation, and increased frequency of immune cells in a cohort of Colombian HIV-1 controllers.
    Taborda NA; Cataño JC; Delgado JC; Rugeles MT; Montoya CJ
    J Acquir Immune Defic Syndr; 2012 May; 60(1):12-9. PubMed ID: 22240462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune activation and antibody responses in non-progressing elite controller individuals infected with HIV-1.
    Bello G; Velasco-de-Castro CA; Bongertz V; Rodrigues CA; Giacoia-Gripp CB; Pilotto JH; Grinsztejn B; Veloso VG; Morgado MG
    J Med Virol; 2009 Oct; 81(10):1681-90. PubMed ID: 19697415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional profiling of CD4 T cells identifies distinct subgroups of HIV-1 elite controllers.
    Vigneault F; Woods M; Buzon MJ; Li C; Pereyra F; Crosby SD; Rychert J; Church G; Martinez-Picado J; Rosenberg ES; Telenti A; Yu XG; Lichterfeld M
    J Virol; 2011 Mar; 85(6):3015-9. PubMed ID: 21177805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Levels of Macrophage Inflammatory Proteins Result in Resistance to R5-Tropic HIV-1 in a Subset of Elite Controllers.
    Walker WE; Kurscheid S; Joshi S; Lopez CA; Goh G; Choi M; Barakat L; Francis J; Fisher A; Kozal M; Zapata H; Shaw A; Lifton R; Sutton RE; Fikrig E
    J Virol; 2015 May; 89(10):5502-14. PubMed ID: 25740989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of plasmacytoid dendritic cell and CD4+ T cell in HIV elite controllers.
    Herbeuval JP; Smith N; Thèze J
    Clin Dev Immunol; 2012; 2012():869505. PubMed ID: 23243424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent Cell-Intrinsic Immune Responses in Dendritic Cells Facilitate HIV-1-Specific T Cell Immunity in HIV-1 Elite Controllers.
    Martin-Gayo E; Buzon MJ; Ouyang Z; Hickman T; Cronin J; Pimenova D; Walker BD; Lichterfeld M; Yu XG
    PLoS Pathog; 2015 Jun; 11(6):e1004930. PubMed ID: 26067651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effector mechanisms in HIV-1 infected elite controllers: highly active immune responses?
    Blankson JN
    Antiviral Res; 2010 Jan; 85(1):295-302. PubMed ID: 19733595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV Interferes with Mycobacterium tuberculosis Antigen Presentation in Human Dendritic Cells.
    Singh SK; Andersson AM; Ellegård R; Lindestam Arlehamn CS; Sette A; Larsson M; Stendahl O; Blomgran R
    Am J Pathol; 2016 Dec; 186(12):3083-3093. PubMed ID: 27746182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy.
    Pereyra F; Addo MM; Kaufmann DE; Liu Y; Miura T; Rathod A; Baker B; Trocha A; Rosenberg R; Mackey E; Ueda P; Lu Z; Cohen D; Wrin T; Petropoulos CJ; Rosenberg ES; Walker BD
    J Infect Dis; 2008 Feb; 197(4):563-71. PubMed ID: 18275276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV+ elite controllers have low HIV-specific T-cell activation yet maintain strong, polyfunctional T-cell responses.
    Owen RE; Heitman JW; Hirschkorn DF; Lanteri MC; Biswas HH; Martin JN; Krone MR; Deeks SG; Norris PJ;
    AIDS; 2010 May; 24(8):1095-105. PubMed ID: 20400885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uniquely altered transcripts are associated with immune preservation in HIV infection.
    Zanoni M; Aventurato ÍK; Hunter J; Sucupira MC; Diaz RS
    PLoS One; 2017; 12(3):e0169868. PubMed ID: 28350860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.